These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29132706)

  • 41. Inappropriate utilization of intravenous proton pump inhibitors in hospital practice--a prospective study of the extent of the problem and predictive factors.
    Craig DG; Thimappa R; Anand V; Sebastian S
    QJM; 2010 May; 103(5):327-35. PubMed ID: 20211846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proton-pump inhibitors and birth defects--some reassurance, but more needed.
    Mitchell AA
    N Engl J Med; 2010 Nov; 363(22):2161-3. PubMed ID: 21105800
    [No Abstract]   [Full Text] [Related]  

  • 43. [Prolonged therapy with proton pump inhibitors: balance of benefits and risks].
    Lazebnik LB; Bordin DS; Masharova AA
    Eksp Klin Gastroenterol; 2010; (9):3-8. PubMed ID: 21427916
    [No Abstract]   [Full Text] [Related]  

  • 44. Correlation between proton pump inhibitors and risk of pyogenic liver abscess.
    Lin HF; Liao KF; Chang CM; Lin CL; Lai SW
    Eur J Clin Pharmacol; 2017 Aug; 73(8):1019-1025. PubMed ID: 28434021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinically relevant interaction between clopidogrel and proton pump inhibitors].
    Alban S; Dingermann T; Griese N; Kämmerer W; Schubert-Zsilavecz M; Schulz M; Trenk D; Zagermann-Muncke P
    Pharm Unserer Zeit; 2009; 38(4):370-1. PubMed ID: 19572357
    [No Abstract]   [Full Text] [Related]  

  • 46. [Selection of proton pump inhibitors in polymorbid patients].
    Uspenskiĭ IuP; Pakhomova IG
    Eksp Klin Gastroenterol; 2013; (2):65-71. PubMed ID: 23947166
    [No Abstract]   [Full Text] [Related]  

  • 47. Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia.
    Johnstone J; Nerenberg K; Loeb M
    Aliment Pharmacol Ther; 2010 Jun; 31(11):1165-77. PubMed ID: 20222914
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proton pump inhibitors and clopidogrel.
    Gaglia MA; Waksman R
    Cardiovasc Ther; 2010 Jun; 28(3):169-76. PubMed ID: 20345494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of recurrent myocardial infarction with the concomitant use of clopidogrel and proton pump inhibitors.
    Valkhoff VE; 't Jong GW; Van Soest EM; Kuipers EJ; Sturkenboom MC
    Aliment Pharmacol Ther; 2011 Jan; 33(1):77-88. PubMed ID: 21083580
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Do proton pump inhibitors increase the risk of myocardial infarction?].
    Horta D; García-Iglesias P; Calvet X
    Gastroenterol Hepatol; 2016; 39(6):365-8. PubMed ID: 26895699
    [No Abstract]   [Full Text] [Related]  

  • 51. Proton pump inhibitors: Oral treatment of pediatric disorders.
    Kumagai H
    Pediatr Int; 2019 Jan; 61(1):5. PubMed ID: 30734429
    [No Abstract]   [Full Text] [Related]  

  • 52. [Validity of proton pump inhibitors' prescriptions in a department of internal medicine].
    Marie I; Moutot A; Tharrasse A; Hellot MF; Robaday S; Hervé F; Lévesque H
    Rev Med Interne; 2007 Feb; 28(2):86-93. PubMed ID: 17092611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The administration of proton-pump inhibitors in little children or patients with difficulties in deglutition].
    De Rocker H
    J Pharm Belg; 2009 Sep; (3):89-90. PubMed ID: 19873849
    [No Abstract]   [Full Text] [Related]  

  • 54. The benefits and risks of proton pump inhibitor therapy.
    Peng YL; Luo JC
    J Chin Med Assoc; 2016 Jan; 79(1):1-2. PubMed ID: 26363687
    [No Abstract]   [Full Text] [Related]  

  • 55. Biological plausibility between proton pump inhibitory therapy and hip fracture: hyperhomocysteinemia can be the link.
    Roblin X; Phelip JM
    Am J Gastroenterol; 2009 Apr; 104(4):1052. PubMed ID: 19240711
    [No Abstract]   [Full Text] [Related]  

  • 56. Proton pump inhibitor use and enteric infections.
    Dial MS
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S10-6. PubMed ID: 19262540
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inappropriate Prescription of Proton Pump Inhibitors in the Setting of Steroid Use: A Teachable Moment.
    Jones MG; Tsega S; Cho HJ
    JAMA Intern Med; 2016 May; 176(5):594-5. PubMed ID: 27065299
    [No Abstract]   [Full Text] [Related]  

  • 58. Clopidogrel and proton pump inhibitor use: what does the evidence really say?
    Baker WL; Coleman CI; Lundbye JB
    Conn Med; 2010 Jan; 74(1):27-31. PubMed ID: 20175370
    [No Abstract]   [Full Text] [Related]  

  • 59. [Antiplatelet drugs and gastrointestinal disorders: when and how effective are inhibitors of proton pump?].
    Ter Arkh; 2011; 83(10):68-71. PubMed ID: 22185030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proton pump inhibitors and the risk of pancreatic cancer.
    Lai SW
    J Gastroenterol; 2021 Mar; 56(3):293-294. PubMed ID: 33544263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.